Literature DB >> 30468489

The roles of NF-kB in the development of lung injury after one-lung ventilation.

W-Z Pan1, J Du, L-Y Zhang, J-H Ma.   

Abstract

OBJECTIVE: To explore the roles of NF-kB in the development of lung injury after one-lung ventilation.
MATERIALS AND METHODS: Eighteen Sprague-Dawley (SD) rats were randomly divided into 3 groups including control group, one-lung ventilation (OL) group and NF-kB inhibitor pyrrolidine dithiocarbamate (PDTC) group, with 6 rats in each group. Rats in OL and PDTC groups were used to establish one-lung ventilation model, and rats in PDTC group were subjected to intravenous injection of NF-kB specific inhibitor PDTC at 30 min before model construction. One-lung ventilation was performed for 3 h, and arterial blood gas analyzer was used for blood gas analysis. The hemodynamics and respiratory mechanics parameters were detected. The respiratory index (RI) and oxygenation index (OI) were calculated. The pathological changes of lung tissue were observed by HE staining. The levels of TNF-α, IL-1β, IL-6, and IL-8 in lung tissue were detected by ELISA. The expression levels of p65, p-p65, p-IκBα and IκBα and the activity of NF-Kβ in lung tissue were detected by Western Blot.
RESULTS: Compared with OL group, HR, RI and W/D were significantly reduced and MAP and OI were significantly increased in PDTC group (p<0.05). Compared with OL group, alveolar fluid exudation, pulmonary interstitial thickening and inflammatory cell infiltration were significantly improved in PDTC group. The levels of TNF-α, IL-1β, IL-6 and IL-8 in PDTC group were significantly lower than in OL group (p<0.05). The ratios of p-p65/p65 and p-IκBα/IκBα and the activity of NF-kB in OL group were significantly reduced than in PDTC group (p<0.05).
CONCLUSIONS: NF-kB can promote lung injury after one-lung ventilation, and the inhibition of NF-kB may be a new way for the treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30468489     DOI: 10.26355/eurrev_201811_16281

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  One-lung ventilation patients: Clinical context of administration of different doses of dexmedetomidine.

Authors:  Hui Jiang; Yu Kang; Chunlin Ge; Zhenying Zhang; Yan Xie
Journal:  J Med Biochem       Date:  2022-04-08       Impact factor: 2.157

2.  Ginkgolide C attenuates lipopolysaccharide‑induced acute lung injury by inhibiting inflammation via regulating the CD40/NF‑κB signaling pathway.

Authors:  Rui Zhang; Nan Guo; Genquan Yan; Qian Wang; Tiantian Gao; Baoke Zhang; Ning Hou
Journal:  Int J Mol Med       Date:  2021-03-02       Impact factor: 4.101

3.  LTB4 Promotes Acute Lung Injury via Upregulating the PLCε-1/TLR4/NF-κB Pathway in One-Lung Ventilation.

Authors:  Jing Luo; Qingjie Ma; Heng Tang; Xi Zou; Xin Guo; Yuzhen Hu; Kejiang Zhou; Rui Liu
Journal:  Dis Markers       Date:  2022-01-11       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.